Bioinformatics Market Growth Accelerated by Integration of Big Data Analytics

 

Bioinformatics Market

Bioinformatics is an interdisciplinary field that combines biology, computer science and information technology to analyze and interpret biological data obtained from high-throughput experiments. Bioinformatics tools are widely used in medical and health applications like drug discovery and development, personalized medicine, medical diagnostics and disease diagnostics. With the increasing prevalence of chronic diseases globally, demand for precision medicine and disease diagnostics using genomics data is growing rapidly. Advances in next generation sequencing technologies and reduction in genome sequencing costs have enabled large-scale genome sequencing projects, resulting in tremendous amounts of genomic and other biological data. Analyzing and deriving meaningful insights from this huge volume of complex biological data requires powerful bioinformatics tools and solutions.

 

The global bioinformatics Market is estimated to be valued at US$ 22.1 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Dynamics:

One of the primary drivers for the growth of the bioinformatics market is increasing adoption of genomics technologies. Next generation sequencing technologies have significantly brought down the cost of genome sequencing. This is enabling large-scale genome sequencing projects in healthcare, research and drug discovery domains. For example, over 10 million genomes have been sequenced and analyzed as part of large genome sequencing programs like the UK Biobank and Million Veteran Program in United States. However, the massive amounts of genomic and other biological data generated through projects requires advanced bioinformatics solutions for storage, analysis and interpretation. Hence, growing dependence on genomics is driving demand for more sophisticated and powerful bioinformatics tools and services. Additionally, growing pressure on pharmaceutical companies to reduce the costs and time involved in drug discovery is also fueling adoption of bioinformatics approaches which leverage biological data to identify drug targets and biomarkers. This is further contributing to the market growth over the forecast period.

 

SWOT Analysis

Strength: Bioinformatics uses computational techniques to understand biological data like genetic codes, amino acid sequences, and DNA/RNA sequences. This interdisciplinary approach helps analyze and make meaning of large biological data sets which strengthens medical research and discovery. It enables cost-effective design of drugs and diagnostic tools by integrating information technology with life sciences.

 

Weakness: Setting up bioinformatics infrastructure requires heavy investment in IT capabilities, software, skilled data scientists and domain experts which can be challenging for emerging markets and underdeveloped regions. Additionally, biological data analysis depends highly on algorithm design and continuous upgradation which demands ongoing research and development spending.

 

Opportunity: With technological advances like AI, machine learning, cloud computing and big data analytics, opportunities for bioinformatics are growing exponentially. Vast amounts of biological and health data are being generated through omics research, healthcare practices and patient records. This available data needs to be organised, secured and analyzed for applications in personalized medicine, drug development, agricultural biotechnology etc.

 

Threats: Data security and privacy challenges arise with use of sensitive health and genetic information in bioinformatics research. Regulatory compliances and ethics needs to be strengthened regarding ownership and sharing of biological intellectual property. Additionally, heavy dependence on IT infrastructure and skilled workforce makes the industry vulnerable to macroeconomic changes, talent crunch or technology obsolescence over longer run.

 

Key Takeaways

 

The Global Bioinformatics Market Share is expected to witness high growth on account of increasing research and development spending in life sciences as well as advancements in technologies that aid big data analysis of biological information. The market size for 2024 is estimated to reach US$ 22.1 Bn registering a CAGR of over 10% during the forecast period of 2023 to 2030.

 

Regional analysis- North America currently dominates the global bioinformatics market with the highest research and development investments and presence of leading industry players and academic institutions. Meanwhile, Asia Pacific is identified as the fastest growing region due to increasing healthcare awareness, expanding biotech hubs and favorable government initiatives in countries like China, India and Japan.

 

Key players operating in the bioinformatics market are The 3M Company, Thermo Fisher Scientific Inc., Illumina Inc., PerkinElmer Inc., QIAGEN N.V., Agilent Technologies Inc., Dassault Systèmes SE, Eurofins Scientific, Waters Corporation and BGI Group. The companies are focused on building strategic collaborations, acquisitions, new product launches and expanding into emerging markets through joint ventures to gain competitive advantage.

 

Get More Insights Here

https://www.newswirestats.com/bioinformatics-market-industry-insights-trends-bioinformatics-market/